European shares start week on firm footing, vaccine developments eyed

  • Reuters
  • Stock Market News
European shares start week on firm footing, vaccine developments eyed
Credit: © Reuters.

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

Sept 7 (Reuters) - European shares rebounded on Monday after a Wall Street-led rout in technology stocks kept global sentiment subdued in the previous week, with investors keeping a close watch on COVID-19 vaccine developments.

Australia expects to receive its first batches of a potential COVID-19 vaccine in January after a deal was struck with CSL CSL.AX to manufacture two vaccines - one developed by rival AstraZeneca AZN.L and Oxford University, and another in CSL's own labs with the University of Queensland. rose 1.5%. The European healthcare sector index .SXDP jumped 0.9%.

The STOXX 600 index .STOXX was 0.8% higher by 0709 GMT, with Frankfurt shares .GDAXI leading gains after rising 1%.

Shares of insurers .SXIP , banks .SX7P and automakers .SXAP climbed more than 1% in early trading.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100